Vizient Member Networks Pharmacy Network Meeting

Anaheim, NV US
December 2, 2023

This activity will provide participants with knowledge, approaches, and ideas related to leadership, communication, technology, pharmacy practice, and pharmacy operations and finances. The knowledge, approaches, and ideas should be used by participants to compare to their individual practice sites and develop an action plan to improve their practices. Additionally, the activity will encourage networking to develop relationships that can be used during and after the meeting to share experiences and provide mentorship in completion of action plans.

Target Audience

This activity is intended for pharmacists. 

Learning Objectives

Pharmacists learning objectives

At the conclusion of this activity, pharmacists should be able to:

AI & Automation in the Pharmacy – Applications, Aspirations, and Ambiguities

  • Describe current applications in the hospital and the pharmacy.
  • Discuss the emerging opportunities for AI to drive workflow efficiencies, clinical outcomes, and operational improvements.
  • Examine the known unknowns, potential pitfalls, and early “best practices” for adopting AI tools in healthcare.

Washington Update

  • Describe dynamics in Congress that are impacting health care policy.
  • State examples of steps government agencies have taken to address drug shortages.
  • Discuss federal legislative and regulatory key advocacy issues impact hospital pharmacies.

Leveraging Systems to Impact Positive Outcomes and Regulatory Considerations

  • Discuss strategies to optimize medication management, patient safety, and regulatory compliance.

Optimizing Processes and Workflows

  • Review opportunities to optimize pharmacy operations practices.

Special Populations and Community Programs

  • Identify opportunities for pharmacists to improve patient care.

Safety, Data, and Standardization

  • Demonstrate strategies for pharmacy-drive initiatives which positively contribute to the well-being of an organization.
  • Discuss systems to impact positive outcomes.

Pharmacy Executives

  • Describe strategies to address patient access.
  • Describe the characteristics of top performing organizations from years of research and member interviews.
  • Identify how the pharmacy executive plays a key role in the success and sustained performance of their organization.
  • Explain how best to leverage data/analytics, benchmarking, and networking activities as key elements to optimal organizational performance.
  • Discuss pharmacy relevant contemporary hot topics.
Course summary
Available credit: 
  • 4.75 ACPE Pharmacist
  • 4.75 General CE - Attendance
Course opens: 
Course expires: 
Event starts: 
12/02/2023 - 9:15am CST
Event ends: 
12/02/2023 - 3:30pm CST
Anaheim Marriot
700 W Convention Way
Anaheim, NV 92802
United States


Aira Paclibar, CPhT
Pharmacy Technician Supervisor
UCSF Benioff Children’s Hospital/UCSF Medical Center at Mission Bay

Amy E. Wainright, PharmD, BCACP, BCGP
Clinical Pharmacist, Ambulatory Pharmacy
University of Chicago Medicine

Ariel Thurmer, PharmD, BCPS
System Clinical Manager – Pharmacy Services
SSM Health

Benjamin Glennon, PharmD
Outpatient Pharmacy Manager - Centralized Services
Froedtert and the Medical College of Wisconsin

Brian D. Kennedy, RPh, MBA/HCM
Senior Manager Pharmacy Clinical Practice
Mayo Clinic

Chelsee J. Jensen, PharmD, BCPS, RPh
Senior Pharmacy Specialist, Pharmaceutical Formulary Manager
Supply Chain Management
Mayo Clinic

Chris Nering
Pharmacy Data Science and Automation Team Lead

Christian R. Pecore, MBA
Administrative Fellow - Medical College Physicians
Froedtert and the Medical College of Wisconsin

Craig Lane, BBA
Manager Application and Technical Services
Texas Children's Hospital 

Dawn Whiting, PharmD, BCPS
Assistant Director of Acute Care Pharmacy Clinical Services
Denver Health and Hospital Authority 

Elizabeth Spoede, MS, RD, CSP, LD
Clinical Nutrition Specialist
Texas Children's Hospital 

Emily Buchanan, PharmD, BCPS
Clinical Pharmacy Manager – Medication Safety Officer
SSM Health 

Eric Cabie, RPh, MBA
Associate Director of Oncology Pharmacy Services
Smilow Cancer Center, Yale-New Haven Hospital 

Eric Tichy, PharmD, BCPS, FCCP
FAST Division Chair
Mayo Clinic

Gretchen Brummel, PharmD, BCPS
Pharmacy Executive Director
Vizient, Inc. 

Han Dinh, PharmD, BCPS
Inpatient Pharmacy Supervisor-La Jolla Campus
UC San Diego Health 

Hyesoo Chae, PharmD, MBA, BCPS
System-Wide Manager, Pharmacy Perioperative Services - Pharmaceutical Services Department
University of California, San Francisco Medical Center 

Jenna Stearn, JD
AVP, Regulatory Affairs & Public Policy
Vizient, Inc.

Jessica Benjamin, PharmD
System Clinical Director – Pharmacy Services
SSM Health 

John Kapisarov, PharmD
Clinical Informatics Pharmacist
University of California, San Francisco Health 

Jordan Spillane, PharmD
Director, Ambulatory Pharmacy Services
Froedtert Health  

Ju Young (Jason) Song, PharmD
Senior Pharmacy Specialist     
Smilow Cancer Center, Yale-New Haven Hospital  

Karen Nolan, RPh, MBA, DPLA
Director of Inpatient Pharmacy
Rhode Island Hospital

Kassandra Bugg, PharmD, BCACP
Pharmacists Supervisor
University of California, Davis Health 

Louis Palmisciano, BS IT
Manager Outcomes and Impact

Luciano Sanchez, PharmD
University of California, Davis Health  

Pooja Shah, PharmD, BCPS, 340B ACE
340B Programs Pharmacy Manager
UNC Health

Rachael England, MPH
Associate Principal, Digital Technologies
Vizient, Inc. 

Rachel Drury, PharmD, BCACP
Ambulatory Pharmacy Manager
Froedtert Health  

Sam Abdelghany, PharmD, MHA, BCOP
Executive Director, Oncology Pharmacy Services
Yale New Haven Hospital 


Planning committee

Rebecca Petti, PharmD, MBA, BCPS, BCPPS, FCCP
Pediatric Pulmonary Clinical Pharmacy
Program Director, Pediatric PGY2 Residency
Riley Hospital for Children, Indiana University Health

Pooja Shah, PharmD, BCPS, 340B ACE
340B Programs Pharmacy Manager
UNC Health

Sybil Thomas, PharmD, MBA
Associate Vice President, Member Connections
Vizient, Inc.

Identification, Mitigation, and Disclosure of Relevant Financial Relationships

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.

It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.

Disclosure of Relevant Financial Relationships:

Relevant Financial Relationships 

Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.

Amy E. Wainright, PharmD, BCACP, BCGP, speaker for this educational activity, is a speaker for AbbVie. 

Chelsee J. Jensen, PharmD, BCPS, RPh, speaker for this educational activity, is a consultant for Amgen and advisory board member for Aptitude Health. 

Eric Tichy, PharmD, BCPS, FCCP, speaker for this educational activity, is an advisory board member for GlaxoSmithKline and Pfizer, Inc. and a speaker for Takeda Pharmaceuticals, Inc. 
All relevant financial relationships listed for these individual(s) have been mitigated.

All others in a position to control content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Statement of content validity

Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.

FDA off-label/unapproved usage

Faculty/Presenters are required to identify any new and evolving topics for which there is a lower/absence of evidence base. This is to ensure that our content does not advocate for, or promote, practices that are not, or not yet adequately based on current science, evidence, and clinical reasoning. Faculty/Presenters are required to disclose any discussion of (1) off-label/unapproved or investigational uses of FDA approved commercial products or devices and/or (2) products or devices not yet approved in the United States.

Disclaimer: The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.

Joint Accreditation Statement:

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


Designation Statements:


Vizient, Inc. designates this activity for a maximum of 4.75 ACPE credit hours.

Universal Activity Number: JA0006103-0000-23-137-L04-P


Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re- certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.

Available Credit

  • 4.75 ACPE Pharmacist
  • 4.75 General CE - Attendance
Please login or register to take this course.